Immunovia AB (publ) (IMMVF)
USD 0.07
(0.0%)
USD 0.07
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 4.28 Million SEK | -88.59% |
| 2022 | 37.57 Million SEK | 12.96% |
| 2021 | 33.26 Million SEK | 0.4% |
| 2020 | 33.13 Million SEK | -12.96% |
| 2019 | 38.06 Million SEK | 0.0% |
| 2018 | - SEK | 0.0% |
| 2017 | - SEK | 0.0% |
| 2016 | - SEK | 0.0% |
| 2015 | - SEK | 0.0% |
| 2014 | - SEK | 0.0% |
| 2013 | - SEK | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 8.79 Million SEK | 105.16% |
| 2024 Q2 | 8.7 Million SEK | -0.99% |
| 2023 Q3 | 26.28 Million SEK | -5.96% |
| 2023 FY | 4.28 Million SEK | -88.59% |
| 2023 Q2 | 27.95 Million SEK | -22.21% |
| 2023 Q1 | 35.93 Million SEK | -4.36% |
| 2023 Q4 | 4.28 Million SEK | -83.7% |
| 2022 Q3 | 39.86 Million SEK | -1.28% |
| 2022 FY | 37.57 Million SEK | 12.96% |
| 2022 Q1 | 40.74 Million SEK | 22.5% |
| 2022 Q2 | 40.38 Million SEK | -0.89% |
| 2022 Q4 | 37.57 Million SEK | -5.76% |
| 2021 Q1 | 37.54 Million SEK | 13.33% |
| 2021 FY | 33.26 Million SEK | 0.4% |
| 2021 Q4 | 33.26 Million SEK | -3.69% |
| 2021 Q3 | 34.53 Million SEK | -4.16% |
| 2021 Q2 | 36.03 Million SEK | -4.04% |
| 2020 Q3 | 34.37 Million SEK | -3.37% |
| 2020 Q1 | 36.84 Million SEK | -3.2% |
| 2020 Q4 | 33.13 Million SEK | -3.62% |
| 2020 FY | 33.13 Million SEK | -12.96% |
| 2020 Q2 | 35.57 Million SEK | -3.46% |
| 2019 Q1 | 34.21 Million SEK | 0.0% |
| 2019 Q4 | 38.06 Million SEK | 0.14% |
| 2019 Q2 | 33.33 Million SEK | -2.56% |
| 2019 FY | 38.06 Million SEK | 0.0% |
| 2019 Q3 | 38.01 Million SEK | 14.03% |
| 2018 Q4 | - SEK | 0.0% |
| 2018 FY | - SEK | 0.0% |
| 2018 Q3 | - SEK | 0.0% |
| 2018 Q1 | - SEK | 0.0% |
| 2018 Q2 | - SEK | 0.0% |
| 2017 Q2 | - SEK | 0.0% |
| 2017 FY | - SEK | 0.0% |
| 2017 Q4 | - SEK | 0.0% |
| 2017 Q3 | - SEK | 0.0% |
| 2017 Q1 | - SEK | 0.0% |
| 2016 Q2 | - SEK | 0.0% |
| 2016 FY | - SEK | 0.0% |
| 2016 Q1 | - SEK | 0.0% |
| 2016 Q4 | - SEK | 0.0% |
| 2015 Q1 | - SEK | 0.0% |
| 2015 Q2 | - SEK | 0.0% |
| 2015 Q4 | - SEK | 0.0% |
| 2015 Q3 | - SEK | 0.0% |
| 2015 FY | - SEK | 0.0% |
| 2014 Q1 | - SEK | 0.0% |
| 2014 Q4 | - SEK | 0.0% |
| 2014 Q3 | - SEK | 0.0% |
| 2014 FY | - SEK | 0.0% |
| 2013 FY | - SEK | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| American Bio Medica Corporation | 2.24 Million USD | -91.339% |
| Arrayit Corporation | 1.07 Million USD | -297.527% |
| Atlantic International Corp. | 2.93 Million USD | -46.256% |
| Biocept, Inc. | 12.1 Million USD | 64.605% |
| Bioqual, Inc. | 3.58 Million USD | -19.488% |
| CardioGenics Holdings Inc | 72.61 Thousand USD | -5802.443% |
| DermTech, Inc. | 54.39 Million USD | 92.12% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 471.86 Million USD | 99.092% |
| HTG Molecular Diagnostics, Inc. | 4.83 Million USD | 11.335% |
| iMD Companies, Inc. | 1.12 Million USD | -282.628% |
| IDenta Corp. | 789.14 Thousand USD | -443.119% |
| Interpace Biosciences, Inc. | 11.19 Million USD | 61.705% |
| Integrative Health Technologies, Inc. | - USD | -Infinity% |
| InVitro International | 43.84 Thousand USD | -9675.345% |
| Lumos Diagnostics Holdings Limited | 8.04 Million USD | 46.724% |
| Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
| Medical Imaging Corp. | 3.82 Million USD | -12.026% |
| NovelStem International Corp. | 3.57 Million USD | -19.902% |
| Optigenex Inc. | 8.94 Million USD | 52.062% |
| PharmChem, Inc. | 77.35 Thousand USD | -5440.832% |
| Proteome Sciences plc | 17.15 Million USD | 75.014% |
| Response Genetics, Inc | 6.37 Million USD | 32.748% |
| Rennova Health, Inc. | 15.32 Million USD | 72.041% |
| RushNet, Inc. | 4.82 Million USD | 11.136% |
| ScreenPro Security Inc. | 207.03 Thousand USD | -1970.191% |
| Stella Diagnostics Inc. | 6.2 Million USD | 30.879% |
| StageZero Life Sciences Ltd. | 1.8 Million USD | -138.1% |
| Todos Medical Ltd. | 38.34 Million USD | 88.823% |